-
Medicines / ImmunologyCell and Gene TherapyFuture of HealthcareInnovationMedical InnovationsPatient EducationPatient VoicesReimagine MedicineScientific ResearchImmunologyThe Future of Autoimmune Disease: A Q&A You Need to Read
1 in 5 Americans lives with an autoimmune disease, yet many have no or very limited treatment options. Christy Siegel, SVP and TA Head, Immunology, Novartis US, shares how we aim to change that.
MedicinesImmunology -
MedicinesBiomedical JobsBiomedical ResearchCareersDrug DiscoveryEmerging TechnologyScientific ResearchWorking at NovartisMeet Colin: A Novartis Scientist Looking for New Breakthroughs
Colin works on a cryo-electron microscope the size of a room using a process that earned a team of scientists a Nobel Prize. Learn how his work is advancing the ways we treat disease.
Medicines -
MedicinesAccess to HealthcareInnovationOncologyReimagine MedicineCarter’s Story: My Mom's Journey with Cancer Inspired Me. Now I Help Make Medicines for Patients
For Carter Jaynes, helping to produce doses of RLT is deeply personal. See how a move to our new RLT facility in Carlsbad can help him reach even more patients.
Medicines -
MedicinesOncologyFuture of HealthcareReimagine MedicineInnovationWorking at NovartisBuilding for the Future: Novartis Expands Manufacturing Hub in North Carolina
The creation of a 700,000-square-foot flagship manufacturing hub marks the continuation of our investment in the US, enabling us to more reliably reach patients across the country.
Medicines -
Medicines / Patient VoicesReimagine MedicineLearning from the experiences of the Chronic myeloid leukemia (CML) community
Novartis explores how to improve the CML patient and provider experience from pre-diagnosis to care management at CML SummitMedicinesPatient Voices -
MedicinesBiomedical JobsData ScienceDigitalNext Generation ScientistNovartis looks to the brightest academic minds to reimagine metastatic breast cancer treatment
More than 16 teams from US universities participated in the first US oncology data science hackathon to tackle current challenges in metastatic breast cancer treatments.
Medicines